Regional Vice President of Sales
Rad AI120,000 - 140,000 USD/year
- Full Time
- Senior (5 to 8 years)
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Medical Diagnostics, Prenatal and Cancer DiagnosticsIndustries
Requirements
The ideal candidate should possess 15+ years of progressive sales leadership experience in the laboratory/diagnostics industry, with proven success in building and managing a team of 100 or more sales representatives through a multi-layer team structure, experience scaling sales organizations in high-growth environments, and a deep understanding of healthcare provider sales cycles and decision-making processes. Experience in specialty molecular diagnostics, particularly women’s health and/or prenatal market, is preferred, along with a Bachelor’s degree and an MBA or advanced degree.
Responsibilities
The Vice President of Prenatal Sales will be responsible for developing and executing comprehensive sales strategies to drive adoption of Unity Complete™ and related prenatal testing solutions, building and scaling the sales team structure, leading, mentoring, and supporting Sales Directors and their regional teams to drive performance and growth, driving revenue growth and consistently meeting or exceeding sales targets, designing and implementing territory expansion plans, collaborating cross-functionally with Marketing, Product, Operations, and other departments, building and maintaining relationships with key opinion leaders, major healthcare systems, and strategic accounts, providing regular reporting and insights to Executive Leadership Team, continuously refining sales processes, tools, and methodologies, and fostering a culture of excellence within the sales organization. They will also represent BillionToOne at industry conferences and events.
Skills
Sales Strategy
Team Building
Leadership
Mentoring
Prenatal Testing
Product Adoption
Revenue Growth
BillionToOne
Molecular diagnostics for prenatal and oncology testing
About BillionToOne
BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair resolution, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne emphasizes accuracy, efficiency, and accessibility in molecular testing, providing diagnostic services directly to healthcare providers. Their goal is to positively impact healthcare by making molecular testing more reliable and available to everyone.
Key Metrics
Menlo Park, CaliforniaHeadquarters
2016Year Founded
$380.2MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees